A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variants and Severe Renal Impairment
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This is an Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in
Fabry Subjects With Amenable GLA Variants and Severe Renal Impairment